Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04986670 · ClinicalTrials.gov registry record · NA

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

A NA study of Lung Cancer, Non-Small Cell and Lung Cancer Metastatic, sponsored by Tufts University.

Active
Registry status
NA
Development phase
299
Enrollment target
4
Study locations

NCT04986670: Active NA study of Lung Cancer, Non-Small Cell and Lung Cancer Metastatic, sponsored by Tufts University.

NCT04986670 is a NA study of Lung Cancer, Non-Small Cell and Lung Cancer Metastatic that is active but no longer recruiting, run by Tufts University. The registered enrollment target is 299 participants, below the 437-participant average among 16 other Lung Cancer, Non-Small Cell trials with a reported enrollment target (32% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04986670, a NA study of Lung Cancer, Non-Small Cell and Lung Cancer Metastatic, is active but no longer recruiting, sponsored by Tufts University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
299 participants
Enrollment target
4
Study locations

Study Summary

The NutriCare study aims to develop, implement, and evaluate the efficacy of an innovative intervention strategy (medically tailored meals plus nutrition counseling) to integrate nutrition into the standard of care for oncology to improve outcomes of vulnerable patients with lung cancer. The NutriCare study evaluates the efficacy of the intervention on optimizing nutritional status, reducing treatment-related toxicities, and improving the quality of life of patients with lung cancer who are economically disadvantaged, uninsured, racial and ethnic minorities, elderly, and/or rural residents from four major medical centers in diverse regions of the United States (U.S.). There will be two cohorts for NutriCare with cohort 1 recruiting 150 patients completing an 8-month intervention and cohort 2 recruiting 120 patients completing a 6-month intervention.

Primary Outcome

Change in diet quality and intake of key food groups and nutrients as assessed by the National Cancer Institute Diet History Questionnaire (DHQ III)

Interventions

  • BEHAVIORAL Nutritional Counseling
  • OTHER Medically Tailored Meals (MTMs)
  • BEHAVIORAL Nutrition Prescription
  • OTHER Nutrition Assessment
  • BEHAVIORAL Nutrition Toolkit

Study Locations (4)

Massachusetts

  • Tufts Medical Center - Boston

Ohio

  • The James Cancer Hospital - Columbus

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 299 participants
Start Date 2020-11-24
Est. Completion 2026-12-31
Phase NA
Tufts University

163 total trials

What the registry record for NCT04986670 still lists

NCT04986670 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 437-participant average among 16 other Lung Cancer, Non-Small Cell trials with a reported enrollment target (32% lower).

The record links to 6 conditions, with Lung Cancer, Non-Small Cell appearing as the primary indexed condition, and to 5 interventions - of which Nutritional Counseling is the first listed.

NCT04986670 reports a single indexed study location in Massachusetts, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04986670 about?

NCT04986670 is a clinical study titled "NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer". The NutriCare study aims to develop, implement, and evaluate the efficacy of an innovative intervention strategy (medically tailored meals plus nutrition counseling) to integrate nutrition into the standard of care for oncology to improve outcomes of vulnerable patients with lung cancer. The NutriCa...

What is the current status of trial NCT04986670?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 299 participants. The study started on 2020-11-24. Estimated completion is 2026-12-31.

What conditions does trial NCT04986670 study?

This clinical trial studies the following conditions: Lung Cancer, Non-Small Cell, Lung Cancer Metastatic, Treatment Side Effects, Lung Cancer, Small Cell, Lung Cancer Recurrent.

What interventions are being tested in trial NCT04986670?

The interventions under investigation include: Nutritional Counseling (BEHAVIORAL), Medically Tailored Meals (MTMs) (OTHER), Nutrition Prescription (BEHAVIORAL), Nutrition Assessment (OTHER), Nutrition Toolkit (BEHAVIORAL).

Who is sponsoring clinical trial NCT04986670?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04986670 being conducted?

This trial has 4 study locations across Massachusetts, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer, Non-Small Cell

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04986670's enrollment target sits among peer trials

299 7th of 16 higher than 10 of 16 other Lung Cancer, Non-Small Cell trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer, Non-Small Cell trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04986670, the US trial registry maintained by the National Library of Medicine. NCT04986670 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.